These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33609743)

  • 21. Trans sodium crocetinate with temozolomide and radiation therapy for glioblastoma multiforme.
    Gainer JL; Sheehan JP; Larner JM; Jones DR
    J Neurosurg; 2017 Feb; 126(2):460-466. PubMed ID: 27177177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of linear accelerator and helical tomotherapy plans for glioblastoma multiforme patients.
    Koca T; Basaran H; Sezen D; Karaca S; Ors Y; Arslan D; Aydin A
    Asian Pac J Cancer Prev; 2014; 15(18):7811-6. PubMed ID: 25292068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
    Mallick S; Kunhiparambath H; Gupta S; Benson R; Sharma S; Laviraj MA; Upadhyay AD; Julka PK; Sharma D; Rath GK
    J Neurooncol; 2018 Oct; 140(1):75-82. PubMed ID: 29936695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineligible glioblastoma multiforme patients.
    Coughlin C; Scott C; Langer C; Coia L; Curran W; Rubin P
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1351-8. PubMed ID: 11121633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial.
    Sultanem K; Patrocinio H; Lambert C; Corns R; Leblanc R; Parker W; Shenouda G; Souhami L
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):247-52. PubMed ID: 14697445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Combined Approach Employing Chlorotoxin-Nanovectors and Low Dose Radiation To Reach Infiltrating Tumor Niches in Glioblastoma.
    Tamborini M; Locatelli E; Rasile M; Monaco I; Rodighiero S; Corradini I; Franchini MC; Passoni L; Matteoli M
    ACS Nano; 2016 Feb; 10(2):2509-20. PubMed ID: 26745323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ligand-Mediated and Enzyme-Directed Precise Targeting and Retention for the Enhanced Treatment of Glioblastoma.
    Ruan S; Xiao W; Hu C; Zhang H; Rao J; Wang S; Wang X; He Q; Gao H
    ACS Appl Mater Interfaces; 2017 Jun; 9(24):20348-20360. PubMed ID: 28557433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy.
    Duma CM; Kim BS; Chen PV; Plunkett ME; Mackintosh R; Mathews MS; Casserly RM; Mendez GA; Furman DJ; Smith G; Oh N; Caraway CA; Sanathara AR; Dillman RO; Riley AS; Weiland D; Stemler L; Cannell R; Abrams DA; Smith A; Owen CM; Eisenberg B; Brant-Zawadzki M
    J Neurosurg; 2016 Dec; 125(Suppl 1):40-49. PubMed ID: 27903197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gold nanotriangles: scale up and X-ray radiosensitization effects in mice.
    Bhattarai SR; Derry PJ; Aziz K; Singh PK; Khoo AM; Chadha AS; Liopo A; Zubarev ER; Krishnan S
    Nanoscale; 2017 Apr; 9(16):5085-5093. PubMed ID: 28134383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
    Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
    Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiosensitivity enhancement of radioresistant glioblastoma by epidermal growth factor receptor antibody-conjugated iron-oxide nanoparticles.
    Bouras A; Kaluzova M; Hadjipanayis CG
    J Neurooncol; 2015 Aug; 124(1):13-22. PubMed ID: 25981803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme.
    Nakagawa K; Aoki Y; Fujimaki T; Tago M; Terahara A; Karasawa K; Sakata K; Sasaki Y; Matsutani M; Akanuma A
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1141-9. PubMed ID: 9539570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of trans sodium crocetinate for sensitizing glioblastoma multiforme to radiation: laboratory investigation.
    Sheehan J; Ionescu A; Pouratian N; Hamilton DK; Schlesinger D; Oskouian RJ; Sansur C
    J Neurosurg; 2008 May; 108(5):972-8. PubMed ID: 18447715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current practices and future directions of therapeutic strategy in glioblastoma: survival benefit and indication of BNCT.
    Matsumura A; Yamamoto T; Tsurubuchi T; Matsuda M; Shirakawa M; Nakai K; Endo K; Tokuue K; Tsuboi K
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S12-4. PubMed ID: 19375923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation dose enhancement using gold nanoparticles with a diamond linear accelerator target: a multiple cell type analysis.
    Piccolo O; Lincoln JD; Melong N; Orr BC; Fernandez NR; Borsavage J; Berman JN; Robar J; Ha MN
    Sci Rep; 2022 Jan; 12(1):1559. PubMed ID: 35091583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utilization of hypofractionated radiotherapy in treatment of glioblastoma multiforme in elderly patients not receiving adjuvant chemoradiotherapy: A National Cancer Database Analysis.
    Bingham B; Patel CG; Shinohara ET; Attia A
    J Neurooncol; 2018 Jan; 136(2):385-394. PubMed ID: 29209874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Theranostic Application of Mixed Gold and Superparamagnetic Iron Oxide Nanoparticle Micelles in Glioblastoma Multiforme.
    Sun L; Joh DY; Al-Zaki A; Stangl M; Murty S; Davis JJ; Baumann BC; Alonso-Basanta M; Kaol GD; Tsourkas A; Dorsey JF
    J Biomed Nanotechnol; 2016 Feb; 12(2):347-56. PubMed ID: 27305768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropathological postmortem evaluation of BNCT for GBM.
    H-Stenstam B; Pellettieri L; Sköld K; Rezaei A; Brun A
    Acta Neurol Scand; 2007 Sep; 116(3):169-76. PubMed ID: 17714330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced production of reactive oxygen species by gadolinium oxide nanoparticles under core-inner-shell excitation by proton or monochromatic X-ray irradiation: implication of the contribution from the interatomic de-excitation-mediated nanoradiator effect to dose enhancement.
    Seo SJ; Han SM; Cho JH; Hyodo K; Zaboronok A; You H; Peach K; Hill MA; Kim JK
    Radiat Environ Biophys; 2015 Nov; 54(4):423-31. PubMed ID: 26242374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.